The Founder and Vice Chairman of Healthequity (NASDAQ: HQY) is Buying Shares

By Carrie Williams

Today, the Founder and Vice Chairman of Healthequity (HQYResearch Report), Stephen Neeleman, bought shares of HQY for $610K.

Following Stephen Neeleman’s last HQY Buy transaction on June 19, 2017, the stock climbed by 20.3%. In addition to Stephen Neeleman, 3 other HQY executives reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Based on Healthequity’s latest earnings report for the quarter ending April 30, the company posted quarterly revenue of $87.05 million and quarterly net profit of $41.82 million. In comparison, last year the company earned revenue of $69.9 million and had a net profit of $22.58 million. HQY’s market cap is $4.49B and the company has a P/E ratio of 48.90. Currently, Healthequity has an average volume of 1.14M.

Based on 8 analyst ratings, the analyst consensus is Strong Buy with an average price target of $86.29, reflecting a 22.6% upside. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy HQY with a $95 price target. Six different firms, including Barrington and Cantor Fitzgerald, currently also have a Buy rating on the stock.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors.